Alba Bioscience Ortho Sera Anti-Lea and Anti-Leb - HSA Registration DE0510323
Access comprehensive regulatory information for Alba Bioscience Ortho Sera Anti-Lea and Anti-Leb in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0510323 and owned by ALBA Bioscience Limited. The device was registered on February 10, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Anti-Lea reagent is for the qualitative in vitro detection of human Lea positive red blood cells by the direct agglutination test. The Anti-Leb reagent is for the qualitative in vitro detection of human Leb positive red blood cells by the direct agglutination test.